Atlas Trials

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

Clinical trial NCT05573282 · UNKNOWN

Trial details

NCT number
NCT05573282
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2022-10-16
Primary completion
2025-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.